Jun 2026 (Q2 FY26) — Aug 6, 2026
iRhythm Holdings, Inc. Q2 FY26 — Strong Growth, Margin Expansion, and Strategic Acquisition
Read the full calliRhythm Holdings (IRTC) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
iRhythm Holdings earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 224 | +20.1% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -1.1 | +8.9 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -0.38 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$109.6 +0.87% · +$0.94
Performance −39.7% 1Y
1Y: $181.8 on 17 Oct 2025 → $109.6. High $189.25 (8 Jan 2026), low $101.79 (17 Jun 2026).
- Previous close
- $108.66
- 52-week range
- $101.79 – $189.25
- One year
- −39.86%
Overview
- Symbol
- IRTC
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
iRhythm Holdings earnings calls (IRTC)
Financials
What the filings say
Net profit, year on year: +97% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 148 | 164 | 159 | 187 | 193 | 209 | 199 | 224 |
| Operating profit | -50 | -4 | -33 | -19 | -8 | 2 | -16 | -3 |
| Operating margin | −34.1% | −2.5% | −20.5% | −10.0% | −4.4% | 1.1% | −8.1% | −1.1% |
| Other income | 4 | 3 | 3 | 4 | 3 | 4 | 3 | 2 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | -46 | -1 | -30 | -14 | -5 | 6 | -13 | -0 |
| Tax rate | −0.4% | −12.8% | −2.2% | 1.3% | −0.5% | 7.4% | −3.7% | 0.0% |
| Net profit | -46 | -1 | -31 | -14 | -5 | 6 | -14 | -0 |
| EPS ($ per share) | -1.48 | — | -0.97 | -0.44 | -0.16 | — | -0.43 | -0.01 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -206 | -260 | -305 | -406 | -522 | -646 | -759 | -803 |
| Total liabilities | 65 | 171 | 170 | 183 | 208 | 223 | 841 | 867 |
| Fixed assets | 9 | 26 | 34 | 56 | 76 | 104 | 125 | 152 |
| Investments | — | — | — | 112 | 134 | 98 | 116 | 348 |
| Total assets | 118 | 306 | 512 | 463 | 448 | 433 | 931 | 1,020 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -29 | -22 | -14 | -38 | -23 | -50 | 3 | 81 |
| Cash from investing | 34 | -89 | -132 | 105 | -52 | -1 | -123 | -277 |
| Cash from financing | 6 | 112 | 214 | -29 | 27 | 9 | 511 | 13 |
| Net cash flow | 11 | 0 | 68 | 39 | -49 | -43 | 392 | -184 |
| Capital expenditure | -5 | -20 | -14 | -28 | -30 | -40 | -34 | -46 |
| Free cash flow | -34 | -42 | -27 | -66 | -53 | -91 | -31 | 35 |
Insider filings
109 filings between Oct 31, 2025 and Sep 2, 2026.
Open market
decisions to buy or sellPurchases
$56.9K
1 purchase by 1 insider
Sales
$29.64M
66 sales by 12 insiders
30% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 40
- Award — granted as compensation
- 2
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Blackford Quentin S. | — | $11.15M | Aug 10, 2026 |
| Patterson Chad | — | $3.05M | Aug 10, 2026 |
| Murphy Patrick Michael | — | $2.96M | Aug 10, 2026 |
| Wilson Daniel G. | — | $2.89M | Sep 2, 2026 |
| Turakhia Minang | — | $2.64M | Aug 10, 2026 |
| TALWALKAR ABHIJIT Y | $56.9K | $2.33M | May 11, 2026 |
| Shrishrimal Sumi | — | $2.06M | Aug 10, 2026 |
| Smith Mervin | — | $1.19M | Aug 3, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Wilson Daniel G. Chief Financial Officer | Sale | 773 | $94.2K |
| Aug 10, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Sale | 7,093 | $884.2K |
| Aug 10, 2026 | Murphy Patrick Michael CBO and CLO | Sale | 7,093 | $884.2K |
| Aug 10, 2026 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Sale | 7,093 | $884.2K |
| Aug 10, 2026 | Blackford Quentin S. President and CEO | Sale | 26,859 | $3.35M |
| Aug 10, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | 5,372 | $669.6K |
| Aug 7, 2026 | Murphy Patrick Michael CBO and CLO | Award | 13,589 | $0 |
| Aug 7, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Award | 13,589 | $0 |
| Aug 7, 2026 | Blackford Quentin S. President and CEO | Award | 48,534 | $0 |
| Aug 7, 2026 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Award | 13,589 | $0 |
| Aug 7, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Award | 9,706 | $0 |
| Aug 3, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Sale | 2,712 | $331.2K |
| Aug 3, 2026 | Smith Mervin EVP Strategic Business Ops | Sale | 617 | $75.3K |
| Aug 3, 2026 | Rodda Julianne EVP, CHIEF PEOPLE OFFICER | Sale | 2,112 | $257.9K |
| Jul 2, 2026 | Freeman Sean Clinton EVP, Strategy & Corp Devt | Sale | 918 | $114.5K |
| Jul 2, 2026 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Sale | 1,423 | $177.5K |
| Jun 2, 2026 | Rosenbaum Marc W. Chief Accounting Officer | Sale | 729 | $78.9K |
| Jun 2, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | 1,716 | $185.7K |
| May 29, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Award | 133 | $12.9K |
| May 29, 2026 | Rosenbaum Marc W. Chief Accounting Officer | Award | 178 | $17.2K |
| May 29, 2026 | Blackford Quentin S. President and CEO | Award | 178 | $17.2K |
| May 29, 2026 | Freeman Sean Clinton EVP, Strategy & Corp Devt | Award | 273 | $26.4K |
| May 29, 2026 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Award | 137 | $13.3K |
| May 29, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Award | 177 | $17.1K |
| May 27, 2026 | Bodaken Bruce G. Director | Award | 1,573 | $0 |
| May 27, 2026 | Ling Karen Director | Award | 1,573 | $0 |
| May 27, 2026 | MCGINNIS KAREN K Director | Award | 1,573 | $0 |
| May 27, 2026 | TALWALKAR ABHIJIT Y Director | Award | 1,573 | $0 |
| May 27, 2026 | Bairey Merz Cathleen Noel Director | Award | 1,573 | $0 |
| May 27, 2026 | YOOR BRIAN B Director | Award | 1,573 | $0 |
| May 27, 2026 | OBOYLE KEVIN C Director | Award | 1,573 | $0 |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 plan | 940 | $109.1K |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 plan | 290 | $35.0K |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Purchase 10b5-1 plan | 5,312 | $56.9K |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 plan | 1,147 | $136.7K |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 plan | 2,293 | $270.6K |
| May 11, 2026 | TALWALKAR ABHIJIT Y Director | Sale 10b5-1 plan | 642 | $75.1K |
| May 4, 2026 | Lawrence Brian Lee Chief Technology Officer | Sale | 1,014 | $122.5K |
| Mar 16, 2026 | Smith Mervin EVP Strategic Business Ops | Sale 10b5-1 plan | 2,585 | $295.5K |
| Mar 12, 2026 | Patten Jason H Director | Award | 2,218 | $0 |
| Mar 2, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | 978 | $125.6K |
| Mar 2, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | 906 | $116.4K |
| Mar 2, 2026 | Shrishrimal Sumi EVP, Chief Risk Officer | Sale | 946 | $121.5K |
| Mar 2, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Sale | 3,030 | $389.2K |
| Mar 2, 2026 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Sale | 1,414 | $181.6K |
| Mar 2, 2026 | Murphy Patrick Michael CBO and CLO | Sale | 1,139 | $146.3K |
| Mar 2, 2026 | Murphy Patrick Michael CBO and CLO | Sale | 1,190 | $152.8K |
| Mar 2, 2026 | Murphy Patrick Michael CBO and CLO | Sale | 2,028 | $260.5K |
| Mar 2, 2026 | Blackford Quentin S. President and CEO | Sale | 5,423 | $696.6K |
| Mar 2, 2026 | Blackford Quentin S. President and CEO | Sale | 4,043 | $519.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for iRhythm Holdings, Inc.
Free account. Everything above stays public.
Write why you follow iRhythm Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading